IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307 | +429.3% | 19,406 | +27.4% | 0.00% | – |
| Q1 2023 | $58 | -100.0% | 15,232 | -48.2% | 0.00% | – |
| Q2 2022 | $132,000 | +109.5% | 29,389 | +161.1% | 0.00% | – |
| Q3 2021 | $63,000 | +34.0% | 11,256 | +93.8% | 0.00% | – |
| Q1 2021 | $47,000 | -93.5% | 5,807 | -92.1% | 0.00% | -100.0% |
| Q2 2018 | $718,000 | -7.5% | 73,858 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $776,000 | +108.6% | 73,858 | +27.2% | 0.00% | 0.0% |
| Q4 2017 | $372,000 | – | 58,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |